Future Africa led the seed round to help Liquify expand its invoice financing marketplace across Sub-Saharan Africa.
"We built Liquify to unlock the $120 billion trade-finance gap holding back Africa’s most dynamic SMEs. This seed round – as well the incredible people joining our team – validates our vision. With our fully digital, AI-powered platform, exporters can turn unpaid invoices into same-day cash, while global investors gain access to a new untapped class. Since its beta launch in late 2024, Liquify has facilitated over 150 transactions, totaling $4 million in trade financed. With funding secured, we embark on our next chapter: deepening our technology, growing our team in Ghana, and scaling across Sub-Saharan Africa."
The financing round was led by Insight Partners with participation from a16z Speedrun, Atomico, Begin Capital, and Zero Prime.
"As more and more models launch, devs can have tens or even hundreds of endpoints to integrate with and maintain. Runware solves this problem by delivering access to all the models, at the best price, with the best inference time. We see model providers now moving to our platform and offering their APIs from our inference pod, because we can deliver 90% lower inference cost than any cloud provider."
The financing round was led by Ahren Innovation Capital and will support the expansion of the company's in-house target discovery programme.
"OutSee’s Nomaly technology is a truly next-generation genomic analysis tool with potential to transform drug discovery using powerful data-driven insights. It allows us to interrogate smaller datasets, and even data that has already been analysed, to uncover unique target insights that until now would have remained undetected."
The pre-seed round was backed by Regulatory Scientific and Health Solutions and angel investors to support product development and team growth.
"We founded Giles AI to dramatically accelerate clinical and medical research using secure, cutting-edge, conversational AI. The impact is transformative: a typical 10-year, $1.5bn drug or device development pipeline can be accelerated significantly – getting life-saving innovations to market faster than ever before. With our collaboration with Google, our recent £750K pre-seed raise gives us the runway to scale rapidly -FounderCatalyst were instrumental facilitating the raise, providing expert legal guidance and an incredibly efficient process that let us stay focused on building the future of medical research."
